AARTIPHARMPharmaceuticals
Aarti Pharmalabs Ltd — Balance Sheet
₹591.95
-4.72%
Aarti Pharmalabs Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 9.06 Cr | 9.06 Cr | 9.06 Cr | 9.06 Cr | — |
| Share Issued | 9.06 Cr | 9.06 Cr | 9.06 Cr | 9.06 Cr | — |
| Net Debt | 389.62 Cr | 240.47 Cr | 202.21 Cr | 255.35 Cr | — |
| Total Debt | 413.12 Cr | 285.25 Cr | 215.31 Cr | 341.40 Cr | — |
| Tangible Book Value | 1.89K Cr | 1.68K Cr | 1.52K Cr | 1.36K Cr | — |
| Invested Capital | 2.39K Cr | 2.02K Cr | 1.77K Cr | 1.73K Cr | — |
| Working Capital | 665.12 Cr | 651.25 Cr | 562.38 Cr | 447.48 Cr | — |
| Net Tangible Assets | 1.89K Cr | 1.68K Cr | 1.52K Cr | 1.36K Cr | — |
| Capital Lease Obligations | 16.76 Cr | 21.15 Cr | 0.98 Cr | 2.78 Cr | — |
| Common Stock Equity | 1.99K Cr | 1.76K Cr | 1.56K Cr | 1.39K Cr | — |
| Total Capitalization | 2.09K Cr | 1.76K Cr | 1.56K Cr | 1.39K Cr | — |
| Total Equity Gross Minority Interest | 1.99K Cr | 1.76K Cr | 1.56K Cr | 1.39K Cr | — |
| Stockholders Equity | 1.99K Cr | 1.76K Cr | 1.56K Cr | 1.39K Cr | — |
| Other Equity Interest | 1.94K Cr | 0.23 Cr | 1.51K Cr | 45.31 Cr | — |
| Capital Stock | 45.32 Cr | 45.31 Cr | 45.31 Cr | 0.25 Cr | — |
| Common Stock | 45.32 Cr | 45.31 Cr | 45.31 Cr | 0.25 Cr | — |
| Total Liabilities Net Minority Interest | 916.50 Cr | 825.07 Cr | 685.54 Cr | 653.42 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 259.45 Cr | 130.68 Cr | 84.91 Cr | 72.76 Cr | — |
| Other Non Current Liabilities | 1000.00 | -1000.00 | 0.01 Cr | 2000.00 | — |
| Non Current Deferred Taxes Liabilities | 128.40 Cr | 107.92 Cr | 78.84 Cr | 70.67 Cr | — |
| Long Term Debt And Capital Lease Obligation | 115.22 Cr | 16.70 Cr | 0.72 Cr | 2.09 Cr | — |
| Long Term Capital Lease Obligation | 11.67 Cr | 16.66 Cr | 0.53 Cr | 1.53 Cr | — |
| Long Term Debt | 103.56 Cr | 0.04 Cr | 0.18 Cr | 0.55 Cr | — |
| Long Term Provisions | 8.12 Cr | 6.06 Cr | 1.32 Cr | — | — |
| Current Liabilities | 657.05 Cr | 694.39 Cr | 600.62 Cr | 580.66 Cr | — |
| Other Current Liabilities | 17.10 Cr | 5.37 Cr | 2.74 Cr | 1.52 Cr | — |
| Current Debt And Capital Lease Obligation | 297.89 Cr | 268.56 Cr | 214.60 Cr | 339.31 Cr | — |
| Current Capital Lease Obligation | 5.09 Cr | 4.49 Cr | 0.44 Cr | 1.24 Cr | — |
| Current Debt | 292.80 Cr | 264.06 Cr | 214.15 Cr | 338.07 Cr | — |
| Current Provisions | 11.74 Cr | 6.31 Cr | 11.21 Cr | 8.96 Cr | — |
| Payables | 278.98 Cr | 404.11 Cr | 364.13 Cr | 222.09 Cr | — |
| Total Tax Payable | 1.14 Cr | 0.00 | 3.52 Cr | 7.50 Cr | — |
| Accounts Payable | 277.83 Cr | 378.32 Cr | 339.50 Cr | 214.59 Cr | — |
| Total Assets | 2.91K Cr | 2.58K Cr | 2.24K Cr | 2.04K Cr | — |
| Total Non Current Assets | 1.58K Cr | 1.24K Cr | 1.08K Cr | 1.01K Cr | — |
| Other Non Current Assets | 22.75 Cr | -4000.00 | -1000.00 | -3000.00 | — |
| Investmentin Financial Assets | 43.27 Cr | 31.12 Cr | 29.86 Cr | 32.23 Cr | — |
| Available For Sale Securities | 43.27 Cr | 31.12 Cr | 29.86 Cr | 32.23 Cr | — |
| Goodwill And Other Intangible Assets | 100.22 Cr | 77.05 Cr | 41.63 Cr | 24.15 Cr | — |
| Other Intangible Assets | 98.44 Cr | 75.27 Cr | 39.85 Cr | 22.37 Cr | — |
| Goodwill | 1.78 Cr | 1.78 Cr | 1.78 Cr | 1.78 Cr | — |
| Net PPE | 1.41K Cr | 1.11K Cr | 988.57 Cr | 946.42 Cr | — |
| Gross PPE | 1.41K Cr | 1.64K Cr | 1.46K Cr | 946.42 Cr | — |
| Construction In Progress | 306.58 Cr | 90.76 Cr | 64.70 Cr | 166.33 Cr | — |
| Other Properties | 1.10K Cr | 1.01K Cr | 923.88 Cr | 780.09 Cr | — |
| Current Assets | 1.32K Cr | 1.35K Cr | 1.16K Cr | 1.03K Cr | — |
| Other Current Assets | 96.82 Cr | 2000.00 | 7.58 Cr | -15000.00 | — |
| Inventory | 587.58 Cr | 642.86 Cr | 602.04 Cr | 475.45 Cr | — |
| Other Receivables | 1.01 Cr | 12.11 Cr | 6.62 Cr | 12.68 Cr | — |
| Taxes Receivable | 0.00 | 3.44 Cr | 0.00 | 75.89 Cr | — |
| Accounts Receivable | 575.40 Cr | 519.34 Cr | 450.10 Cr | 376.66 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 61.35 Cr | 94.03 Cr | 63.11 Cr | 83.27 Cr | — |
| Other Short Term Investments | 54.61 Cr | 70.40 Cr | 50.99 Cr | — | — |
| Cash And Cash Equivalents | 6.73 Cr | 23.63 Cr | 12.12 Cr | 83.27 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Minority Interest | — | 0.00 | — | — | — |
| Retained Earnings | — | 1.09K Cr | 889.39 Cr | 717.24 Cr | -0.02 Cr |
| Additional Paid In Capital | — | 440.58 Cr | 440.58 Cr | 440.33 Cr | 0.00 |
| Non Current Pension And Other Postretirement Benefit Plans | — | 6.06 Cr | 5.36 Cr | — | — |
| Pensionand Other Post Retirement Benefit Plans Current | — | 6.31 Cr | 5.50 Cr | 8.78 Cr | 0.00 |
| Other Payable | — | 25.65 Cr | 21.04 Cr | — | — |
| Dividends Payable | — | 0.14 Cr | 0.07 Cr | — | — |
| Non Current Prepaid Assets | — | 11.33 Cr | 9.44 Cr | 8.58 Cr | 0.00 |
| Long Term Equity Investment | — | 5.66 Cr | 5.66 Cr | 28.55 Cr | 0.00 |
| Investments In Other Ventures Under Equity Method | — | 5.66 Cr | 5.66 Cr | 28.55 Cr | 0.00 |
| Accumulated Depreciation | — | -536.85 Cr | -467.57 Cr | -405.11 Cr | 0.00 |
| Machinery Furniture Equipment | — | 1.28K Cr | 1.16K Cr | 994.08 Cr | 0.00 |
| Buildings And Improvements | — | 194.70 Cr | 163.54 Cr | 126.13 Cr | 0.00 |
| Land And Improvements | — | 77.94 Cr | 66.93 Cr | 64.99 Cr | 0.00 |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.43 Cr | 0.07 Cr | 0.00 | — |
| Prepaid Assets | — | 73.42 Cr | 41.06 Cr | 4.20 Cr | 0.00 |
| Other Inventories | — | 2.14 Cr | 2.63 Cr | 2.19 Cr | — |
| Finished Goods | — | 296.65 Cr | 265.31 Cr | 190.22 Cr | 0.00 |
| Work In Process | — | 128.87 Cr | 140.26 Cr | 90.06 Cr | 0.00 |
| Raw Materials | — | 215.20 Cr | 193.83 Cr | 192.98 Cr | 0.00 |
| Allowance For Doubtful Accounts Receivable | — | -2.24 Cr | -2.50 Cr | — | — |
| Gross Accounts Receivable | — | 521.59 Cr | 452.60 Cr | — | — |
| Cash Financial | — | 23.63 Cr | 12.12 Cr | 26.97 Cr | 0.25 Cr |
| Cash Equivalents | — | — | 12.81 Cr | 56.31 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Aarti Pharmalabs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.